Skip to main content
UniHealth

Doctor search

Anupama Reddy, MD

Internal Medicine · Palo Alto

NPI 1962554766

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Reddy’s office at (415) 600-1020 to ask if they take your plan before you enroll.

California Medical Board record

Licence A56173 · Current

Licensed to practise in California · since 1996 · expires 2028-04-30 · Nagarjuna University, Siddhartha Medical College.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Original Medicare doctor bills

$43,030

Medicare paid this office $43,030 for 297 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)169$19,036$106
Long return visit (40+ min)91$14,185$156
Short return visit (20+ min)32$2,210$69
Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b14$1,957$140
Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus11$1,538$140
See all 12 services
Every Original Medicare service billed
Return visit (30+ min)169$19,036$106
Long return visit (40+ min)91$14,185$156
Short return visit (20+ min)32$2,210$69
Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b14$1,957$140
Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus11$1,538$140
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen17$855$50
Injection of drug or substance under skin or into muscle25$357$13
Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)11$178$16
Inhalation treatment for airway obstruction or sputum production14$113$8
Automated urinalysis test32$73$2
Injection, ceftriaxone sodium, per 250 mg22$28None
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg14$1None

Who their Medicare patients are

297 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 14% · Women 60% · Also on Medicaid 22% · Health risk score 1.09. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.

Conditions among them: High blood pressure 72% · Diabetes 35% · Coronary heart disease 29% · Chronic kidney disease 22% · Heart failure 14% · Cancer 13% · Atrial fibrillation 13% · Depression 11% · COPD 8% · Dementia 6% · Stroke 4%.

The office billed $147,536, Medicare allowed $59,534 and paid $43,030; for 599 services of 29 kinds; $129 of it was for drugs given in the office and $42,901 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024297599751.09$147,536$43,030
2023295686741.09$147,188$42,823
2022285606761.06$137,567$41,896
2021234401751.04$93,684$30,467
2020153794761.23$60,739$15,385
2019345732741.26$136,807$36,829
2018305713741.24$116,415$29,302
2017337958741.32$124,996$34,026
2016301850731.16$106,469$25,926
2015287742741.28$101,874$27,455
2014272581731.20$95,804$25,731
2013244387741.23$74,957$19,979

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 12 services

Original Medicare services billed in 2023
Return visit (30+ min)150$17,077$109
Long return visit (40+ min)68$11,464$166
Short return visit (20+ min)34$2,825$81
New patient visit (30+ min)29$2,524$84
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen42$2,112$50
New patient visit (45+ min)15$2,069$138
Injection of drug or substance under skin or into muscle33$465$12
Detection test by immunoassay with direct visual observation for influenza virus20$357$16
Inhalation treatment for airway obstruction or sputum production11$108$10
Automated urinalysis test37$84$2
Injection, ceftriaxone sodium, per 250 mg24$38None
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg26$2None

2022: 12 services

Original Medicare services billed in 2022
Return visit (30+ min)95$11,247$116
Long return visit (40+ min)46$8,186$171
New patient visit (30+ min)64$6,079$95
New patient visit (45+ min)31$4,467$144
Short return visit (20+ min)41$3,103$74
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen57$2,993$51
New patient visit (15+ min)13$846$65
Injection of drug or substance under skin or into muscle24$350$13
Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)11$179$16
Automated urinalysis test36$80$2
Blood glucose (sugar) test performed by hand-held instrument13$42$3
Injection, ceftriaxone sodium, per 250 mg21$33None

2021: 8 services

Original Medicare services billed in 2021
Return visit (30+ min)96$12,171$117
Long return visit (40+ min)56$9,228$162
New patient visit (30+ min)27$2,842$105
Short return visit (20+ min)35$2,817$78
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen11$667$51
Injection of drug or substance under skin or into muscle15$237$14
Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)12$198$17
Automated urinalysis test27$63$2

2020: 6 services

Original Medicare services billed in 2020
Return visit (30+ min)104$9,311$86
Long return visit (40+ min)19$2,553$134
Short return visit (20+ min)23$1,261$55
Injection of drug or substance under skin or into muscle12$182$13
Automated urinalysis test16$36$2
Injection, ceftriaxone sodium, per 250 mg11$19None

2019: 9 services

Original Medicare services billed in 2019
Return visit (30+ min)284$28,266$93
Short return visit (20+ min)49$3,006$61
New patient visit (30+ min)11$862$78
Inhalation treatment for airway obstruction or sputum production31$608$18
Injection of drug or substance under skin or into muscle19$333$16
Automated urinalysis test41$105$2
Infusion, normal saline solution , 1000 cc13$27None
Injection, ceftriaxone sodium, per 250 mg13$25None
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg29$3None

2018: 7 services

Original Medicare services billed in 2018
Return visit (30+ min)259$23,187$83
Short return visit (20+ min)33$1,914$56
Injection of drug or substance under skin or into muscle27$594$20
Inhalation treatment for airway obstruction or sputum production27$523$19
Automated urinalysis test25$70$3
Injection, ceftriaxone sodium, per 250 mg17$36None
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg28$3None

2017: 8 services

Original Medicare services billed in 2017
Return visit (30+ min)268$25,844$88
Short return visit (20+ min)57$3,224$56
Injection of drug or substance into vein11$607$55
Inhalation treatment for airway obstruction or sputum production29$542$19
Injection of drug or substance under skin or into muscle13$398$25
Automated urinalysis test24$72$3
Infusion, normal saline solution , 1000 cc11$25None
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg31$3None

2016: 6 services

Original Medicare services billed in 2016
Return visit (30+ min)235$19,813$78
Short return visit (20+ min)56$2,752$49
Injection of drug or substance under skin or into muscle14$335$22
Automated urinalysis test15$45$3
Injection, ketorolac tromethamine, per 15 mg13$20None
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg14$2None

2015: 6 services

Original Medicare services billed in 2015
Return visit (30+ min)201$18,260$85
Short return visit (20+ min)58$3,478$59
Long return visit (40+ min)17$2,303$135
Automated urinalysis test22$66$3
Injection, ketorolac tromethamine, per 15 mg14$25None
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg11$2None

2014: 4 services

Original Medicare services billed in 2014
Return visit (30+ min)161$13,817$81
Short return visit (20+ min)68$4,101$57
Long return visit (40+ min)23$3,021$126
Automated urinalysis test19$60$3

2013: 3 services

Original Medicare services billed in 2013
Return visit (30+ min)167$14,011$81
Short return visit (20+ min)59$3,073$51
Automated urinalysis test12$37$3

Drugs they prescribed that Part D paid

$21,404

Pharmacies billed $21,404 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

266 generic and fewer than 11 brand-name prescriptions · $21,404 in drug cost · 122 antibiotic prescriptions to 112 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Wixela Inhub11$969$88
Cefdinir19$308$16
Albuterol Sulfate Hfa11$216$20
Doxycycline Hyclate23$193$8
Amoxicillin-Clavulanate Potass17$129$8
See all 8 drugs
Every Part D drug this clinician prescribed
Wixela Inhub11$969$88
Cefdinir19$308$16
Albuterol Sulfate Hfa11$216$20
Doxycycline Hyclate23$193$8
Amoxicillin-Clavulanate Potass17$129$8
Azithromycin36$96$3
Cephalexin18$65$4
Baclofen13$63$5

Year by year

Part D prescribing by year
2024309197NoneNone$21,404
2023344195None11%$13,118
2022288181None7%$8,674
2021190131None9%$7,141
2020153104None14%$4,378
2019343200None17%$18,640
20183211843% (11)18%$17,300
20173602104% (14)23%$21,031
20163381686% (19)None$19,355
20152881537% (19)None$17,573
20142891546% (16)18%$16,393
20133391477% (25)None$17,054

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 8 drugs

Part D drugs prescribed in 2023
Albuterol Sulfate Hfa27$756$28
Doxycycline Hyclate27$304$11
Azithromycin37$183$5
Cefdinir11$175$16
Lidocaine Hcl Viscous18$126$7
Fluticasone Propionate11$90$8
Cephalexin12$66$5
Prednisone16$48$3

2022: 5 drugs

Part D drugs prescribed in 2022
Albuterol Sulfate Hfa19$679$36
Diclofenac17$496$29
Doxycycline Hyclate25$228$9
Amoxicillin-Clavulanate Potass14$124$9
Cephalexin19$88$5

2021: 3 drugs

Part D drugs prescribed in 2021
Diclofenac23$657$29
Doxycycline Hyclate14$226$16
Cephalexin18$76$4

2020: 1 drug

Part D drugs prescribed in 2020
Diclofenac11$313$28

2019: 11 drugs

Part D drugs prescribed in 2019
Flovent Hfa17$6,574$387
Oseltamivir Phosphate12$998$83
Diclofenac13$427$33
Ofloxacin11$359$33
Azithromycin41$349$9
Ondansetron Odt11$212$19
Amoxicillin-Clavulanate Potass14$157$11
Fluticasone Propionate17$147$9
Baclofen11$131$12
Cephalexin25$125$5
Ciprofloxacin11$55$5

2018: 7 drugs

Part D drugs prescribed in 2018
Oseltamivir Phosphate13$1,155$89
Ventolin Hfa12$663$55
Fluticasone Propionate22$247$11
Azithromycin31$175$6
Ciprofloxacin23$159$7
Prednisone17$63$4
Cephalexin13$59$5

2017: 9 drugs

Part D drugs prescribed in 2017
Flovent Hfa12$4,285$357
Ventolin Hfa17$914$54
Fluticasone Propionate28$351$13
Cefdinir11$294$27
Azithromycin43$274$6
Levofloxacin14$147$11
Ciprofloxacin21$107$5
Cephalexin13$98$8
Prednisone13$50$4

2016: 8 drugs

Part D drugs prescribed in 2016
Cefdinir15$450$30
Fluticasone Propionate22$228$10
Lactulose11$212$19
Hydrocodone-Acetaminophen18$197$11
Azithromycin24$153$6
Ciprofloxacin17$112$7
Cephalexin11$60$5
Prednisone11$53$5

2015: 6 drugs

Part D drugs prescribed in 2015
Qvar13$4,864$374
Fluticasone Propionate32$366$11
Azithromycin39$257$7
Hydrocodone-Acetaminophen16$213$13
Ciprofloxacin15$86$6
Amlodipine Besylate12$26$2

2014: 5 drugs

Part D drugs prescribed in 2014
Fluticasone Propionate24$416$17
Azithromycin29$226$8
Cephalexin12$124$10
Hydrocodone-Acetaminophen15$112$7
Ciprofloxacin13$63$5

2013: 4 drugs

Part D drugs prescribed in 2013
Fluticasone Propionate36$874$24
Azithromycin34$300$9
Hydrocodone-Acetaminophen20$196$10
Ciprofloxacin11$68$6

Money from drug and device companies

$134 in 2025

A payment is not proof that care is biased.

Payments by company
BioventusStimrouter Implantable Kit$134
1 payment
  • Meals for Stimrouter Implantable Kit · 2025-08-02 · $134
See the published payment
Every published payment
BioventusMeals · 2025-08-02Stimrouter Implantable Kit$134

Professional record

NPI
1962554766
Licence
CA A56173California A56173: Current · expires 2028-04-30
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Internal medicine (207R00000X)
Mailing address
325 Distel Cir, Los Altos, CA, 94022
NPI first listed
2007-01-18
NPI last updated
2020-05-28
NPI record certified
2020-05-28

This is when the NPI record was last certified, not a medical board exam.